Western blot analysis confirmed increased post-stroke cerebral angiogenesis in HMW-HA treated mice, as presented by higher expression of VEGFR, VEGF2, FGF2, and FGFR1 3 days following MCAO (Fig. 4g, k). The gene discussed is FGFR1; the disease is stroke disorder.